Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Common stock	Additional paidin capital	Accumulated other comprehensive income	Accumulated deficit	Total
Balance at Beginning of period at Dec. 31, 2023	$ 24	$ 339,655	$ 91	$ (320,889)	$ 18,881
Balance at Beginning of period (in shares) at Dec. 31, 2023	24,494,675
Shares withheld for employee taxes		(358)			(358)
Shares withheld for employee taxes (in shares)	(53,743)
Foreign currency translation adjustment			58		58
Stockbased compensation expense		3,273			3,273
Net loss				(28,633)	(28,633)
Issuance of common stock under the employee stock purchase plan		281			281
Issuance of common stock under the employee stock purchase plan (in shares)	58,994
Vesting of share-based awards and exercise of stock options	$ 1	225			226
Vesting of share-based awards and exercise of stock options (in shares)	217,267
Balance at Ending period at Sep. 30, 2024	$ 25	343,076	149	(349,522)	(6,272)
Balance at Ending period (in shares) at Sep. 30, 2024	24,717,193
Balance at Beginning of period at Jun. 30, 2024	$ 25	341,897	98	(339,150)	2,870
Balance at Beginning of period (in shares) at Jun. 30, 2024	24,675,832
Shares withheld for employee taxes		(19)			(19)
Shares withheld for employee taxes (in shares)	(4,366)
Foreign currency translation adjustment			51		51
Stockbased compensation expense		1,081			1,081
Net loss				(10,372)	(10,372)
Issuance of common stock under the employee stock purchase plan		117			117
Issuance of common stock under the employee stock purchase plan (in shares)	31,025
Vesting of share-based awards and exercise of stock options (in shares)	14,702
Balance at Ending period at Sep. 30, 2024	$ 25	343,076	149	(349,522)	(6,272)
Balance at Ending period (in shares) at Sep. 30, 2024	24,717,193
Balance at Beginning of period at Dec. 31, 2024	$ 39	387,059	90	(358,730)	28,458
Balance at Beginning of period (in shares) at Dec. 31, 2024	39,395,712
Vesting of restricted stock units	$ 1				1
Vesting of restricted stock units (in shares)	268,601
Shares withheld for employee taxes		(201)			(201)
Shares withheld for employee taxes (in shares)	(81,013)
Exercise of pre-funded warrant		(1)			(1)
Exercise of pre-funded warrant (in shares)	700,000
Foreign currency translation adjustment			1		1
Stockbased compensation expense		2,984			2,984
Net loss				(29,790)	(29,790)
Issuance of common stock under the employee stock purchase plan		105			105
Issuance of common stock under the employee stock purchase plan (in shares)	58,235
Balance at Ending period at Sep. 30, 2025	$ 40	389,946	91	(388,520)	1,557
Balance at Ending period (in shares) at Sep. 30, 2025	40,341,535
Balance at Beginning of period at Jun. 30, 2025	$ 40	388,968	93	(379,917)	9,184
Balance at Beginning of period (in shares) at Jun. 30, 2025	39,584,178
Vesting of restricted stock units (in shares)	37,590
Shares withheld for employee taxes		(21)			(21)
Shares withheld for employee taxes (in shares)	(11,150)
Exercise of pre-funded warrant		(1)			(1)
Exercise of pre-funded warrant (in shares)	700,000
Foreign currency translation adjustment			(2)		(2)
Stockbased compensation expense		955			955
Net loss				(8,603)	(8,603)
Issuance of common stock under the employee stock purchase plan		45			45
Issuance of common stock under the employee stock purchase plan (in shares)	30,917
Balance at Ending period at Sep. 30, 2025	$ 40	$ 389,946	$ 91	$ (388,520)	$ 1,557
Balance at Ending period (in shares) at Sep. 30, 2025	40,341,535